Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor. | Sci Rep | 2022 | 36319719 | PubTator, text mining | PubMed |
| Suicide risk and mental health in the general population of French Polynesia. | J Int Med Res | 2022 | 36314885 | PubTator, text mining | PubMed |
| Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification. | Thorac Cancer | 2022 | 36305094 | PubTator, text mining | PubMed |
| The multiple de novo copy number variant (MdnCNV) phenomenon presents with peri-zygotic DNA mutational signatures and multilocus pathogenic variation. | Genome Med | 2022 | 36303224 | PubTator, text mining | PubMed |
| Familial Esophageal Cancer in Taihang Mountain, China: An Era of Personalized Medicine Based on Family and Population Perspective. | Cell Transplant | 2022 | 36300368 | PubTator, text mining | PubMed |
| Micro-CT Evaluation of Different Root Canal Irrigation Protocols on the Removal of Accumulated Hard Tissue Debris: A Systematic Review and Meta-Analysis. | J Clin Med | 2022 | 36294374 | PubTator, text mining | PubMed |
| The Manufacture of Xeno- and Feeder-Free Clinical-Grade Human Embryonic Stem Cell Lines: First Step for Cell Therapy. | Int J Mol Sci | 2022 | 36293356 | PubTator, text mining | PubMed |
| Response of the Urothelial Carcinoma Cell Lines to Cisplatin. | Int J Mol Sci | 2022 | 36293346 | PubTator, text mining | PubMed |
| Cisplatin Resistance: Genetic and Epigenetic Factors Involved. | Biomolecules | 2022 | 36291573 | PubTator, text mining | PubMed |
| TP53 Mutation Mapping in Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Cohort Study. | Curr Oncol | 2022 | 36290859 | PubTator, text mining | PubMed |
| Neuroprotective Effect of Abelmoschus manihot Flower Extracts against the H2O2-Induced Cytotoxicity, Oxidative Stress and Inflammation in PC12 Cells. | Bioengineering (Basel) | 2022 | 36290563 | PubTator, text mining | PubMed |
| Phosphorylation of the DNA repair scaffold SLX4 drives folding of the SAP domain and activation of the MUS81-EME1 endonuclease. | Cell Rep | 2022 | 36288699 | PubTator, text mining | PubMed |
| Autosomal recessive progeroid syndrome due to homozygosity for a TOMM7 variant. | J Clin Invest | 2022 | 36282599 | PubTator, text mining | PubMed |
| The roles of MMP8/MMP10 polymorphisms in ischemic stroke susceptibility. | Brain Behav | 2022 | 36282475 | PubTator, text mining | PubMed |
Individualized combination therapies based on whole-exome sequencing displayed significant clinical benefits in a glioblastoma patient with secondary osteosarcoma: case report and genetic characterization. | BMC Neurol | 2022 | 36271359 | PubTator, text mining | PubMed |
| Genomic landscape of lung cancer in the young. | Front Oncol | 2022 | 36263208 | PubTator, text mining | PubMed |
| The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment. | J Hematol Oncol | 2022 | 36253861 | PubTator, text mining | PubMed |
| Editorial: Targeting DNA repair and the DNA damage response: Beyond the standard PI3 kinase-like kinases. | Front Oncol | 2022 | 36237323 | PubTator, text mining | PubMed |
| A 3D Collagen-Based Bioprinted Model to Study Osteosarcoma Invasiveness and Drug Response. | Polymers (Basel) | 2022 | 36236019 | PubTator, text mining | PubMed |
| Metallo-Drugs in Cancer Therapy: Past, Present and Future. | Molecules | 2022 | 36235023 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=23